S&P 500   4,256.04 (-0.65%)
DOW   33,847.55 (-0.45%)
QQQ   326.00 (-1.00%)
AAPL   173.29 (-0.49%)
MSFT   288.69 (-0.51%)
META   171.20 (-1.98%)
GOOGL   119.13 (-0.87%)
AMZN   140.70 (-1.12%)
TSLA   898.38 (-1.13%)
NVDA   184.84 (-1.54%)
NIO   19.65 (-1.31%)
BABA   90.15 (-0.65%)
AMD   99.22 (-1.21%)
T   18.40 (-0.16%)
MU   61.88 (-1.75%)
CGC   3.68 (-3.41%)
F   15.95 (-1.24%)
GE   78.28 (-1.17%)
DIS   121.51 (-0.95%)
AMC   18.20 (-5.65%)
PYPL   98.10 (-1.76%)
PFE   48.70 (+0.25%)
NFLX   242.00 (-1.29%)
S&P 500   4,256.04 (-0.65%)
DOW   33,847.55 (-0.45%)
QQQ   326.00 (-1.00%)
AAPL   173.29 (-0.49%)
MSFT   288.69 (-0.51%)
META   171.20 (-1.98%)
GOOGL   119.13 (-0.87%)
AMZN   140.70 (-1.12%)
TSLA   898.38 (-1.13%)
NVDA   184.84 (-1.54%)
NIO   19.65 (-1.31%)
BABA   90.15 (-0.65%)
AMD   99.22 (-1.21%)
T   18.40 (-0.16%)
MU   61.88 (-1.75%)
CGC   3.68 (-3.41%)
F   15.95 (-1.24%)
GE   78.28 (-1.17%)
DIS   121.51 (-0.95%)
AMC   18.20 (-5.65%)
PYPL   98.10 (-1.76%)
PFE   48.70 (+0.25%)
NFLX   242.00 (-1.29%)
S&P 500   4,256.04 (-0.65%)
DOW   33,847.55 (-0.45%)
QQQ   326.00 (-1.00%)
AAPL   173.29 (-0.49%)
MSFT   288.69 (-0.51%)
META   171.20 (-1.98%)
GOOGL   119.13 (-0.87%)
AMZN   140.70 (-1.12%)
TSLA   898.38 (-1.13%)
NVDA   184.84 (-1.54%)
NIO   19.65 (-1.31%)
BABA   90.15 (-0.65%)
AMD   99.22 (-1.21%)
T   18.40 (-0.16%)
MU   61.88 (-1.75%)
CGC   3.68 (-3.41%)
F   15.95 (-1.24%)
GE   78.28 (-1.17%)
DIS   121.51 (-0.95%)
AMC   18.20 (-5.65%)
PYPL   98.10 (-1.76%)
PFE   48.70 (+0.25%)
NFLX   242.00 (-1.29%)
S&P 500   4,256.04 (-0.65%)
DOW   33,847.55 (-0.45%)
QQQ   326.00 (-1.00%)
AAPL   173.29 (-0.49%)
MSFT   288.69 (-0.51%)
META   171.20 (-1.98%)
GOOGL   119.13 (-0.87%)
AMZN   140.70 (-1.12%)
TSLA   898.38 (-1.13%)
NVDA   184.84 (-1.54%)
NIO   19.65 (-1.31%)
BABA   90.15 (-0.65%)
AMD   99.22 (-1.21%)
T   18.40 (-0.16%)
MU   61.88 (-1.75%)
CGC   3.68 (-3.41%)
F   15.95 (-1.24%)
GE   78.28 (-1.17%)
DIS   121.51 (-0.95%)
AMC   18.20 (-5.65%)
PYPL   98.10 (-1.76%)
PFE   48.70 (+0.25%)
NFLX   242.00 (-1.29%)
NYSE:NUS

Nu Skin Enterprises - NUS Stock Forecast, Price & News

$47.20
+0.23 (+0.49%)
(As of 08/18/2022 12:00 AM ET)
Add
Compare
Today's Range
$46.26
$47.31
50-Day Range
$41.14
$47.20
52-Week Range
$39.40
$56.76
Volume
289,099 shs
Average Volume
358,809 shs
Market Capitalization
$2.37 billion
P/E Ratio
21.26
Dividend Yield
3.28%
Price Target
$61.00

Nu Skin Enterprises MarketRank™ Forecast

Analyst Rating
Hold
2.33 Rating Score
Upside/​Downside
29.2% Upside
$61.00 Price Target
Short Interest
Healthy
5.88% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-2.56
Upright™ Environmental Score
News Sentiment
0.00mentions of Nu Skin Enterprises in the last 14 days
Based on 4 Articles This Week
Insider Trading
Selling Shares
$5.65 M Sold Last Quarter
Proj. Earnings Growth
1.38%
From $3.63 to $3.68 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.36 out of 5 stars

Consumer Staples Sector

49th out of 147 stocks

Drugs, Proprietaries, & Sundries Industry

5th out of 8 stocks

NUS stock logo

About Nu Skin Enterprises (NYSE:NUS) Stock

Nu Skin Enterprises, Inc. develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, LifePak nutritional supplements, ageLOC Meta nutritional supplements, and Beauty Focus Collagen+ skin care supplements, as well as other weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates retail stores and service centers in Mainland China. It sells its products under the Nu Skin, Pharmanex, and ageLOC brands. The company promotes and sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.

Nu Skin Enterprises Price Performance

NUS traded up $0.23 during midday trading on Thursday, hitting $47.20. The stock had a trading volume of 289,099 shares, compared to its average volume of 591,219. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.38 and a current ratio of 2.30. Nu Skin Enterprises has a 1 year low of $39.40 and a 1 year high of $56.76. The business has a fifty day moving average of $44.00 and a 200 day moving average of $46.26. The company has a market cap of $2.37 billion, a P/E ratio of 21.10 and a beta of 1.16.

Nu Skin Enterprises Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 7th. Shareholders of record on Friday, August 26th will be given a $0.385 dividend. The ex-dividend date is Thursday, August 25th. This represents a $1.54 annualized dividend and a yield of 3.26%. Nu Skin Enterprises's payout ratio is currently 69.37%.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on NUS shares. TheStreet lowered Nu Skin Enterprises from a "b" rating to a "c" rating in a report on Thursday, August 4th. Citigroup boosted their price objective on Nu Skin Enterprises from $45.00 to $47.00 and gave the stock a "neutral" rating in a report on Monday, August 8th. Finally, StockNews.com raised Nu Skin Enterprises from a "hold" rating to a "buy" rating in a report on Wednesday, June 22nd. Two investment analysts have rated the stock with a hold rating and two have given a buy rating to the company's stock. According to data from MarketBeat.com, Nu Skin Enterprises has an average rating of "Moderate Buy" and a consensus price target of $61.00.

Insider Buying and Selling at Nu Skin Enterprises

In other Nu Skin Enterprises news, Chairman Steven Lund sold 900 shares of the business's stock in a transaction that occurred on Friday, June 17th. The stock was sold at an average price of $45.01, for a total value of $40,509.00. Following the completion of the sale, the chairman now owns 26,600 shares in the company, valued at $1,197,266. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, Chairman Steven Lund sold 900 shares of the company's stock in a transaction that occurred on Friday, June 17th. The stock was sold at an average price of $45.01, for a total transaction of $40,509.00. Following the completion of the transaction, the chairman now owns 26,600 shares in the company, valued at $1,197,266. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO Ryan S. Napierski sold 25,000 shares of the company's stock in a transaction that occurred on Wednesday, May 25th. The shares were sold at an average price of $44.91, for a total value of $1,122,750.00. Following the transaction, the chief executive officer now owns 122,683 shares of the company's stock, valued at approximately $5,509,693.53. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 126,018 shares of company stock worth $5,645,802. 2.80% of the stock is currently owned by insiders.

Receive NUS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nu Skin Enterprises and its competitors with MarketBeat's FREE daily newsletter.

NUS Stock News Headlines

TheStreet Lowers Nu Skin Enterprises (NYSE:NUS) to C
Nu Skin Enterprises (NUS) Q2 Earnings Lag Estimates
See More Headlines
Receive NUS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nu Skin Enterprises and its competitors with MarketBeat's FREE daily newsletter.

NUS Company Calendar

Last Earnings
11/03/2021
Ex-Dividend for 6/8 Dividend
5/26/2022
Dividend Payable
6/08/2022
Today
8/19/2022
Ex-Dividend for 9/7 Dividend
8/25/2022
Dividend Payable
9/07/2022
Next Earnings (Estimated)
11/02/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Drugs, proprietaries, & sundries
Sub-Industry
Personal Products
CUSIP
67018T10
Employees
4,600
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$61.00
High Stock Price Forecast
$75.00
Low Stock Price Forecast
$47.00
Forecasted Upside/Downside
+29.2%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
3 Analysts

Profitability

Net Income
$147.27 million
Pretax Margin
7.26%

Debt

Sales & Book Value

Annual Sales
$2.70 billion
Cash Flow
$5.82 per share
Book Value
$18.74 per share

Miscellaneous

Free Float
48,802,000
Market Cap
$2.37 billion
Optionable
Optionable
Beta
1.16

Key Executives

  • Mr. Steven J. Lund (Age 69)
    Exec. Chairman
    Comp: $827.03k
  • Mr. Ryan S. Napierski (Age 48)
    Pres, CEO & Director
    Comp: $1.46M
  • Mr. Mark H. Lawrence (Age 52)
    Exec. VP & CFO
    Comp: $918.58k
  • Dr. Joseph Y. Chang Ph.D. (Age 69)
    Exec. VP & Chief Scientific Officer
    Comp: $1.13M
  • Mr. Chayce David Clark (Age 39)
    Exec. VP & Gen. Counsel
    Comp: $540.92k
  • Mr. Ritch N. WoodMr. Ritch N. Wood (Age 56)
    Exec. Advisor
    Comp: $1.53M
  • Mr. D. Matthew DornyMr. D. Matthew Dorny (Age 58)
    Legal Advisor
    Comp: $687.56k
  • Ms. Mang Yee Tang (Age 51)
    Exec. VP and Chief Global Growth & Customer Experience Officer
    Comp: $796.45k
  • Mr. Blake M. Roney (Age 63)
    Founder
  • Ms. Sandra N. Tillotson (Age 65)
    Founder













NUS Stock - Frequently Asked Questions

Should I buy or sell Nu Skin Enterprises stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Nu Skin Enterprises in the last twelve months. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" NUS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NUS, but not buy additional shares or sell existing shares.
View NUS analyst ratings
or view top-rated stocks.

What is Nu Skin Enterprises' stock price forecast for 2022?

3 analysts have issued 1-year target prices for Nu Skin Enterprises' shares. Their NUS share price forecasts range from $47.00 to $75.00. On average, they expect the company's share price to reach $61.00 in the next year. This suggests a possible upside of 29.2% from the stock's current price.
View analysts price targets for NUS
or view top-rated stocks among Wall Street analysts.

How have NUS shares performed in 2022?

Nu Skin Enterprises' stock was trading at $50.75 on January 1st, 2022. Since then, NUS shares have decreased by 7.0% and is now trading at $47.20.
View the best growth stocks for 2022 here
.

When is Nu Skin Enterprises' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 2nd 2022.
View our NUS earnings forecast
.

How were Nu Skin Enterprises' earnings last quarter?

Nu Skin Enterprises, Inc. (NYSE:NUS) announced its quarterly earnings data on Wednesday, November, 3rd. The company reported $0.97 EPS for the quarter, beating analysts' consensus estimates of $0.86 by $0.11. The company earned $641.15 million during the quarter, compared to the consensus estimate of $639.19 million. Nu Skin Enterprises had a net margin of 4.57% and a trailing twelve-month return on equity of 19.78%. During the same period in the prior year, the business earned $1.08 earnings per share.

How often does Nu Skin Enterprises pay dividends? What is the dividend yield for Nu Skin Enterprises?

Nu Skin Enterprises announced a quarterly dividend on Thursday, August 4th. Investors of record on Friday, August 26th will be paid a dividend of $0.385 per share on Wednesday, September 7th. This represents a $1.54 dividend on an annualized basis and a dividend yield of 3.26%. The ex-dividend date is Thursday, August 25th.
Read our dividend analysis for NUS
.

Is Nu Skin Enterprises a good dividend stock?

Nu Skin Enterprises (NYSE:NUS) pays an annual dividend of $1.54 per share and currently has a dividend yield of 3.28%. The company has been increasing its dividend for 23 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 69.37%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, NUS will have a dividend payout ratio of 41.85% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for NUS.

What guidance has Nu Skin Enterprises issued on next quarter's earnings?

Nu Skin Enterprises issued an update on its third quarter 2022 earnings guidance on Thursday, August, 18th. The company provided earnings per share guidance of $0.70-$0.85 for the period, compared to the consensus EPS estimate of $0.89. The company issued revenue guidance of $550.00 million-$590.00 million, compared to the consensus revenue estimate of $630.91 million.

What is Ritch Wood's approval rating as Nu Skin Enterprises' CEO?

72 employees have rated Nu Skin Enterprises Chief Executive Officer Ritch Wood on Glassdoor.com. Ritch Wood has an approval rating of 91% among the company's employees. This puts Ritch Wood in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Nu Skin Enterprises own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nu Skin Enterprises investors own include Alibaba Group (BABA), General Electric (GE), NVIDIA (NVDA), Marathon Petroleum (MPC), Gilead Sciences (GILD), Alphabet (GOOG), Tesla (TSLA), Herbalife Nutrition (HLF), Mastercard (MA) and Netflix (NFLX).

What is Nu Skin Enterprises' stock symbol?

Nu Skin Enterprises trades on the New York Stock Exchange (NYSE) under the ticker symbol "NUS."

Who are Nu Skin Enterprises' major shareholders?

Nu Skin Enterprises' stock is owned by a number of retail and institutional investors. Top institutional investors include State Street Corp (18.25%), Renaissance Technologies LLC (5.62%), AQR Capital Management LLC (1.69%), Aristotle Capital Boston LLC (1.65%), ProShare Advisors LLC (1.41%) and Northern Trust Corp (1.35%). Insiders that own company stock include Andrew D Lipman, D Matthew Dorny, Foulis Greg, James D Thomas, Jeffrey Clark Bettinger, Joseph Y Chang, Mark H Lawrence, Ritch N Wood, Ryan S Napierski and Steven Lund.
View institutional ownership trends
.

How do I buy shares of Nu Skin Enterprises?

Shares of NUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Nu Skin Enterprises' stock price today?

One share of NUS stock can currently be purchased for approximately $47.20.

How much money does Nu Skin Enterprises make?

Nu Skin Enterprises (NYSE:NUS) has a market capitalization of $2.37 billion and generates $2.70 billion in revenue each year. The company earns $147.27 million in net income (profit) each year or $2.22 on an earnings per share basis.

How many employees does Nu Skin Enterprises have?

The company employs 4,600 workers across the globe.

How can I contact Nu Skin Enterprises?

Nu Skin Enterprises' mailing address is 75 WEST CENTER ST, PROVO UT, 84601. The official website for the company is www.nuskinenterprises.com. The company can be reached via phone at (801) 345-1000, via email at investorrelations@nuskin.com, or via fax at 801-345-5999.

This page (NYSE:NUS) was last updated on 8/19/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.